Neoadjuvant hormone therapy for patients with high-risk prostate cancer: a systematic review and meta-analysis

This study aimed to identify the pathological outcomes and survival benefits of neoadjuvant hormone therapy (NHT) combined with radical prostatectomy (RP) and radiotherapy (RT) administered to patients with high-risk prostate cancer (HRPCa). We searched PubMed, Embase, and the Cochrane Library for s...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Wen, Yao, Yu, Liu, Xue, Liu, Yong, Zhang, Gui-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269824/
https://www.ncbi.nlm.nih.gov/pubmed/33586699
http://dx.doi.org/10.4103/aja.aja_96_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269824/
https://www.ncbi.nlm.nih.gov/pubmed/33586699
http://dx.doi.org/10.4103/aja.aja_96_20

Ejemplares similares